Dr. John Neustadt

Dr. John Neustadt

Biography:

Dr. John Neustadt is President of Nutritional Biochemistry, Inc (NBI) and NBI Pharmaceuticals Inc., and medical director of Montana Integrative Medicine. Dr. Neustadt’s research, with his partner Steve Pieczenik, MD, PhD, was the foundation for the Osteo-K product, an osteoporosis supplement that decreases fractures by 87% without any of the dangerous side effects of the medications. Their company, NBI Pharmaceuticals is now working with the FDA’s Orphan Drug division, which has been exceedingly helpful, encouraging and responsive, to create novel therapies for cancer, neurological disorders and mitochondrial diseases.

Dr. Neustadt was voted Best Doctor in the 2008 Best of Bozeman survey, surpassing more than three hundred medical doctors to win this award. He has published more than 100 scholarly research reviews and consumer articles. He is editor of the textbook, Laboratory Evaluations for Integrative and Functional Medicine. Dr. Neustadt, along with Dr. Pieczenik wrote the books, A Revolution in Health through Nutritional Biochemistry, A Revolution in Health, Part 2: How to Take Charge of Your Health, and Foundations and Applications of Medical Biochemistry in Clinical Practice.

Website(s):

Book(s):

Past Shows:

  • Alternative Medicine

    Writer and medical advocate, Julia Schopick began studying alternative medical treatment after her husband developed a cancerous brain tumor. She discussed several promising types of treatments that the medical profession has yet to accept for various life-threatening ailments...More »

Last Night

Strange Forensics / Supernatural Transplants
Strange Forensics / Supernatural Transplants
Crime scene investigator Paul Rimmasch reported on cases of paranormal phenomena experienced in law enforcement. Next, psychic medium Ericka Boussarhane discussed her abilities and how they were heightened after a kidney transplant, as well as gave psychic readings.

Coastzone

CoastZone banner
Sign up for our free CoastZone e-newsletter to receive exclusive daily articles.